« Back to Record
Spraggs, C. C., Parham, L. L., Briley, L. L., Warren, L., Williams, L. L., Fraser, D. D., Jiang, Z., Aziz, Z., Ahmed, S., Demetriou, G., Mehta, A. A., Jackson, N., Byrne, J., Andersson, M., Toi, M., Harris, L., Gralow, J., Zujewski, J. A., Crescenzo, R., Armour, A., Perez, E., & Piccart-Gebhart, M. (2018). Characterisation of the HLA-DRB107:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes. Pharmacogenomics journal, 18(3), 480-486. doi:10.1038/tpj.2017.39
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/278653



